We have a multidisciplinary and bilingual team, made up of international auditors, regulatory affairs experts and quality managers.
Register Products and Pharmaceutical Ingredients in Brazil with a Regulatory Strategy from Day One
Before the Inspection, Certification or Investment: Know Exactly Which Risks Need to Be Addressed
Do you need to validate processes or systems? Specialized personnel? Obtain a certification? Resolve ANVISA non-conformities?
GAP Analysis
– Online
Continuous K and
Regulatory Affairs
– Online
Audit 1
– On-site
Audit 2 – before
Anvisa visit
– On-site
The most important action before achieving GMP certification, it’s set the correct estrategy. That’s why you can count on our multidisciplinary team to help you out.
ANVISA requires all legal and technical submissions to be handled through local legal entities or specialized representatives based in Brazil. Partnering with Kivalita gives your international regulatory team senior local expertise to navigate bureaucracy, communicate natively with inspectors, and dramatically accelerate approval timelines.
ANVISA enforces strict regulations regarding data integrity and software tracking. Our validation protocols are deeply rooted in GAMP 5 principles, seamlessly blending traditional CSV methods with modern CSA (Computer Software Assurance) frameworks to optimize testing based on risk.
We specialize in managing the entire CADIFA (Carta de Adequação de Dossiê de Insumo Farmacêutico Ativo) pipeline. From translating and formatting complex DIFA files to handling technical defense during ANVISA reviews, we make sure your active ingredients are fully compliant to be used by Brazilian pharmaceutical buyers.